:חפש לפי שם
המידע באתר אינו מהווה בשום אופן תחליף להתייעצות עם רופא או רוקח
אין להסתמך על המידע המופיע באתר זה כמקור מידע יחיד
שימוש או צפייה בנתונים באתר זה מעידים על הסכמתך לתנאי השימוש
לחץ/י כאן לצפיה בתנאי השימוש
  אתר ארגון הרוקחות צור קשר שאלות מידע תרופתי אודות המאגר  

:תרופות אחרות בעלות אותם מרכיבים

REMERON 30 MG
REMICADE
REMICADE
 
REMSIMA 100 MG רמסימה 100 מ"ג  
        תרופת מרשם
       


כן, יש ללחוץ כאן לפירוט בסל הבריאות?:
* Rheumatoid arthritis:Remsima, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in:? adult patients with active disease when the response to disease modifying antirheumatic drugs (DMARDs),including methotrexate, has been inadequate.? adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs.In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X ray,has been demonstrated.* Ankylosing spondylitis:Remsima is indicated for treatment of severe, active ankylosing spondylitis, in adult patients who have responded inadequately to conventional therapy.* Psoriatic arthritis:Remsima is indicated for treatment of active and progressive psoriatic arthritis in adult patients when the response to previous DMARD therapy has been inadequate.* Remsima should be administered:? in combination with methotrexate? or alone in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.Infliximab has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.* Psoriasis:Remsima is indicated for treatment of moderate to severe plaque psoriasis in adult patients who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or psoralen ultra-violet A (PUVA)* Adult Crohn?s disease Remsima is indicated for treatment :? of moderately to severely active Crohn?s disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.? treatment of fistulising, active Crohn?s disease, in adult patients who have not responded despite a full and adequate course of therapy with conventional treatment (including antibiotics, drainage and immunosuppressive therapy).* Ulcerative colitis? Remsima is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6 mercaptopurine (6 MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies. התוויה מאושרת:
POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION דרך מתן:
PERRIGO ISRAEL AGENCIES LTD, ISRAEL בעל רישום:
154-60-34158-00 מספר רישום:
רכיב פעיל כמות
INFLIXIMAB 100 MG/VIAL
ATC description
TUMOR NECROSIS FACTOR ALPHA (TNF-ALFA) INHIBITORS
ATC-ניתן ללחוץ על קבוצת ה
STORAGE INFO תנאי אחסון
INFO ON THE WEB מידע ברשת




חזור לחיפוש תרופות | אתר ארגון הרוקחות | צור קשר | שאלות נפוצות | אודות המאגר